US$ 20.34
average weight loss first week on semaglutide Before and After: Real Results Semaglutide Weight Loss Update: 40lbs
Description
Tirzepatide (Dual GIP/GLP-1 Agonist) Tirzepatide activates two hormone receptors instead of one, making it a more advanced option for many patients
"Patients should only use compounding pharmacies when their medication needs cannot be met by an FDA-approved drug," said Shane

Dont make insulin adjustments on your own consult your doctor for guidance

Pharmacokinetics Half-life : ~7 days supports once-weekly dosing Peak plasma concentration : Reached in 13 days post-injection Metabolism : Proteolytic cleavage and -oxidation of fatty acid side chain Excretion : Primarily via urine and feces

But they are: not a cure not metabolically neutral not a substitute for healthy lifestyle & healthspan medicine #GLP1 #CardiometabolicHealth #ObesityMedicine #PreventiveCardiology #Longevity #EvidenceBasedMedici Liesbeth Van RossumLiesbeth Van Rossum is an Influencer Professor of Medicine, internist-endocrinologist at Erasmus MC | European clinical lead obesity and diabetes at the European Society of Endocrinology 2021-2025 | obesity, stress and glucocorticoids | Linkedin Top Voice 49,762 followers

It could be attributed to the fact that the method through which Tirzepatide affects the "nausea center" in the brain is somewhat different than just acting through the GLP-1 pathway
